Literature DB >> 1879973

Tumoricidal alveolar macrophage and tumor infiltrating macrophage cell lines.

A V Palleroni1, L Varesio, R B Wright, M J Brunda.   

Abstract

Continuous alveolar macrophage (AM) and tumor-infiltrated (TIM) cell lines have been generated from C57B16J mice by in vitro infection with the J2 retrovirus carrying the v-raf and v-myc oncogens. Four cloned AM cell lines (AMJ2-C8, AMJ2-C10, AMJ2-C11, AMJ2-C20) and 3 cloned TIM cell lines (TIMJ2-C4, TIMJ2-C7 and TIMJ2-C15) were expanded for further characterization. Flow cytometry detected the product of the raf gene in the cytoplasm of all these cell lines. Studies on the tumoricidal properties of these AM and TIM cell lines demonstrated differences in their response to a panel of known macrophage activators. Four of these cell lines (AMJ2-C8, AMJ2-C10, TIMJ2-C7 and TIMJ2-C15) were activated following exposure to recombinant murine interferon gamma (rMuIFN-gamma) but not lipopolysaccharide (LPS) or muramyl dipeptide (MDP). AMJ2-C20 was only activated by incubation with rMuIFN-gamma plus LPS. AMJ2-C11 and TIMJ2-C4 are the cell lines that most closely resembled the response pattern of the parental AM and TIM, since they could be activated by either the combination of rMuIFN-gamma plus LPS or rMuIFN-gamma plus MDP. Constitutive expression of MHC-class-II antigens was low on AMJ2-C11 or TIMJ2-C4 but was increased following exposure to rMuIFN-gamma. Neither cell line secreted substantial amounts of IL-1 or TNF but both secreted large amounts of IL-6. Thus these cell lines could be powerful tools to study AM and TIM activation and cytotoxicity.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1879973     DOI: 10.1002/ijc.2910490226

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  17 in total

Review 1.  Killing Mycobacterium tuberculosis In Vitro: What Model Systems Can Teach Us.

Authors:  Tracy L Keiser; Georgiana E Purdy
Journal:  Microbiol Spectr       Date:  2017-06

2.  Retinoid X receptor α attenuates host antiviral response by suppressing type I interferon.

Authors:  Feng Ma; Su-Yang Liu; Bahram Razani; Neda Arora; Bing Li; Hiroyuki Kagechika; Peter Tontonoz; Vanessa Núñez; Mercedes Ricote; Genhong Cheng
Journal:  Nat Commun       Date:  2014-11-24       Impact factor: 14.919

3.  Positive feedback regulation of type I interferon by the interferon-stimulated gene STING.

Authors:  Feng Ma; Bing Li; Yongxin Yu; Shankar S Iyer; Mingyu Sun; Genhong Cheng
Journal:  EMBO Rep       Date:  2015-01-08       Impact factor: 8.807

4.  Positive feedback regulation of type I IFN production by the IFN-inducible DNA sensor cGAS.

Authors:  Feng Ma; Bing Li; Su-yang Liu; Shankar S Iyer; Yongxin Yu; Aiping Wu; Genhong Cheng
Journal:  J Immunol       Date:  2015-01-21       Impact factor: 5.422

5.  Intracellular delivery of a cell-penetrating SOCS1 that targets IFN-gamma signaling.

Authors:  Antonio DiGiandomenico; Lukasz S Wylezinski; Jacek Hawiger
Journal:  Sci Signal       Date:  2009-07-21       Impact factor: 8.192

6.  Shigella hijacks the glomulin-cIAPs-inflammasome axis to promote inflammation.

Authors:  Shiho Suzuki; Toshihiko Suzuki; Hitomi Mimuro; Tsunehiro Mizushima; Chihiro Sasakawa
Journal:  EMBO Rep       Date:  2017-11-30       Impact factor: 8.807

7.  Trehalose 6,6'-dimycolate on the surface of Mycobacterium tuberculosis modulates surface marker expression for antigen presentation and costimulation in murine macrophages.

Authors:  Celestine Kan-Sutton; Chinnaswamy Jagannath; Robert L Hunter
Journal:  Microbes Infect       Date:  2008-11-01       Impact factor: 2.700

8.  IFNγ and TNFα mediate CCL22/MDC production in alveolar macrophages after hemorrhage and resuscitation.

Authors:  Nadine Beckmann; Jeffrey M Sutton; Richard S Hoehn; Peter L Jernigan; Lou Ann Friend; Taylor A Johanningman; Rebecca M Schuster; Alex B Lentsch; Charles C Caldwell; Timothy A Pritts
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2020-02-26       Impact factor: 5.464

9.  LincRNA-EPS alleviates severe acute pancreatitis by suppressing HMGB1-triggered inflammation in pancreatic macrophages.

Authors:  Shengchuan Chen; Jingfei Zhu; Li-Qiong Sun; Siying Liu; Tan Zhang; Yuepeng Jin; Chaohao Huang; Dapei Li; Haiping Yao; Jian Huang; Yanghua Qin; Mengtao Zhou; Gang Chen; Qiyu Zhang; Feng Ma
Journal:  Immunology       Date:  2021-03-07       Impact factor: 7.215

10.  Cancer immunotherapy: potential involvement of mediators.

Authors:  S Ben-Efraim
Journal:  Mediators Inflamm       Date:  1997       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.